Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life

This study has been completed.
Actelion Pharmaceuticals Deutschland GmbH
Information provided by (Responsible Party):
Wissenschaftliches Institut Bethanien e.V Identifier:
First received: August 23, 2011
Last updated: June 17, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)